A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E

作者:Assouline Sarit; Culjkovic Kraljacic Biljana; Bergeron Julie; Caplan Stephen; Cocolakis Eftihia; Lambert Caroline; Lau Cara J; Zahreddine Hiba Ahmad; Miller Wilson H Jr; Borden Katherine L B*
来源:Haematologica-The Hematology Journal, 2015, 100(1): E7-E9.
DOI:10.3324/haematol.2014.111245